Off‐label prescriptions of drugs used for the treatment of Crohn’s disease or ulcerative colitis

BACKGROUND: Off‐label prescribing is encountered across various fields of medicine and creates alternative treatment options, but is associated with unknown safety risks. The use of off‐label drugs for the treatment of patients with inflammatory bowel diseases (IBD) has not been characterised before...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Aliment Pharmacol Ther
Päätekijät: Simsek, Melek, Lissenberg‐Witte, Birgit I., van Riswijk, Milou L. M., Verschuren, Sander, Hoentjen, Frank, Oldenburg, Bas, Ponsioen, Cyriel Y., van der Woude, C. Janneke, van der Meulen, Andrea E., Pierik, Marieke, Dijkstra, Gerard, de Boer, Nanne K. H.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2019
Aiheet:
Off‐label Drug Prescribing in Inflammatory Bowel Disease
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6593662/
https://ncbi.nlm.nih.gov/pubmed/30908719
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.15229
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia